Cargando…

Pharmacological Treatment of Major Depressive Disorder in Adolescents

Major depressive disorder (MDD) affects a significant number of adolescents today. Its consequences (including social isolation, failure to achieve crucial developmental milestones, and suicide) mandate close attention in clinical practice. While tricyclics and monoamine oxidase inhibitors (MAOIs) h...

Descripción completa

Detalles Bibliográficos
Autor principal:	Farley, Rachel L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2005
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936544/ https://www.ncbi.nlm.nih.gov/pubmed/15915296 http://dx.doi.org/10.1100/tsw.2005.55

Ejemplares similares

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments
por: Maffioletti, Elisabetta, et al.
Publicado: (2020)

Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
por: Gartlehner, Gerald, et al.
Publicado: (2017)

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
por: Zhu, Yuncheng, et al.
Publicado: (2023)

Achieving adolescent adherence to treatment of major depression
por: Staton, Dennis
Publicado: (2010)

Effectiveness of trauma-focused treatment for adolescents with major depressive disorder
por: Paauw, Corine, et al.
Publicado: (2019)

Major depressive disorder in children and adolescents
por: Mullen, Sandra
Publicado: (2018)

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
por: Atkinson, Sarah, et al.
Publicado: (2018)

Treatment of Major Depressive Disorder in Pediatric Populations
por: Neavin, Drew R., et al.
Publicado: (2018)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
por: Caldiroli, Alice, et al.
Publicado: (2021)

Rediscovering Trazodone for the Treatment of Major Depressive Disorder
por: Fagiolini, Andrea, et al.
Publicado: (2012)

Neurobiological and pharmacological arguments for customization of cognitive behavioral psychotherapy in the treatment of major depressive disorder
por: Ristea, Silvia, et al.
Publicado: (2021)

The effectiveness of electroconvulsive therapy in substance use disorder at pharmacological treatment failure major depression
por: Dannon, P.
Publicado: (2023)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

Levomilnacipran for the treatment of major depressive disorder: a review
por: Asnis, Gregory M, et al.
Publicado: (2015)

The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder
por: Czarny, Piotr, et al.
Publicado: (2021)

Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder
por: Kaur, Mandeep, et al.
Publicado: (2021)

Major depressive disorder: Validated treatments and future challenges
por: Karrouri, Rabie, et al.
Publicado: (2021)

Role of trazodone in treatment of major depressive disorder: an update
por: Fagiolini, Andrea, et al.
Publicado: (2023)

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder
por: McCarthy, Brian, et al.
Publicado: (2023)

An overview of the treatment of eating disorders in adults and adolescents: pharmacology and psychotherapy
por: Costandache, Gina I., et al.
Publicado: (2023)

SUMOylation and Major Depressive Disorder
por: Jeoung, Seok-Won, et al.
Publicado: (2022)

Influence of on emotions and behavior of adolescents with major depressive disorder
por: Lu, Heli, et al.
Publicado: (2023)

Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder
por: Doruk Camsari, Deniz, et al.
Publicado: (2019)

Neurobiology of Major Depressive Disorder
por: Villanueva, Rosa
Publicado: (2013)

Neural Implications of Psychotherapy, Pharmacotherapy, and Combined Treatment in Major Depressive Disorder
por: Schwartz, Thomas L., et al.
Publicado: (2016)

Mechanism of saikogenin G against major depressive disorder determined by network pharmacology
por: Hu, Lili, et al.
Publicado: (2022)

Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review
por: Brockbank, James, et al.
Publicado: (2021)

Continuation treatment of major depressive disorder: is there a case for duloxetine?
por: Norman, Trevor R, et al.
Publicado: (2010)

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020)

Pharmacological Treatments for Patients with Treatment-Resistant Depression
por: Ruberto, Valerie L., et al.
Publicado: (2020)

Pharmacological and Non-pharmacological Treatment Options for Depression and Depressive Symptoms in Hemodialysis Patients
por: Grigoriou, Stefania S., et al.
Publicado: (2015)

Neural correlates of self-perceptions in adolescents with major depressive disorder
por: Bradley, Kailyn A.L., et al.
Publicado: (2016)

Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
por: Demir, Süleyman, et al.
Publicado: (2015)

Network Pharmacology-Based and Experimental Identification of the Effects of Paeoniflorin on Major Depressive Disorder
por: Zhang, Sha, et al.
Publicado: (2022)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Effects of Vortioxetine on Sleep Architecture of Adolescents with Major Depressive Disorder
por: Mlyncekova, Zuzana, et al.
Publicado: (2023)

Effect of Xiaoyaosan on major depressive disorder
por: Jing, Lin-Lin, et al.
Publicado: (2015)

Epigenetic Modifications of Major Depressive Disorder
por: Saavedra, Kathleen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hai0tt226mvnar73jr146gol28